8H0 fundamentals
An in-depth look to POLYPEPTIDE GROUP operating, investing, and financing activities
8H0 free cash flow for H2 23 is 60.58 M CHF. For 2023, 8H0 free cash flow was -15.95 M CHF and operating cash flow was 35.45 M CHF.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
TTM